Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00216320 · ClinicalTrials.gov registry record · NA
Efficacy of the WalkAide and AFOs for CVA
A NA study of Stroke, sponsored by Innovative Neurotronics.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
- 5
- Study locations
NCT00216320: Completed NA study of Stroke, sponsored by Innovative Neurotronics.
NCT00216320 is a NA study of Stroke that has completed, run by Innovative Neurotronics. The registered enrollment target is 121 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00216320, a NA study of Stroke, has completed, sponsored by Innovative Neurotronics.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
- 5
- Study locations
Study Summary
To assess the effectiveness of a new stimulator (WalkAide) for the treatment of foot drop. The comparison will involve physical measurements (e.g. walking speed, physiological cost index, Modified Rivermead Mobility Index, etc.) and questionnaires on the quality of life and acceptance of the technology by stroke survivors.
Primary Outcome
Subjects walked a 10 meter Figure 8 pattern for four minutes at fastest safe speed. This was measured under two conditions: On condition - the WA turned on or the AFO worn by the subject; off condition - The WA turned off or the AFO not worn by the subject. The endpoints were analyzed at 6, and 12 weeks
Conditions Studied
Interventions
- DEVICE WalkAide
- DEVICE AFO
Study Locations (5)
Arizona
- Banner Good Samaritan Medical Center - Phoenix
California
- San Francisco VA Medical Center - San Francisco
Missouri
- Washington University - St Louis
Pennsylvania
- University of Pittsburgh, Department of PM&R - Pittsburgh
Texas
- Texas Institute of Rehabilitation Research - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-11 |
| Phase | NA |
What the finished NCT00216320 record still lists
NCT00216320 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which WalkAide is the first listed.
NCT00216320 lists 5 locations in 5 states (Arizona, California, Missouri).
Frequently Asked Questions
What is clinical trial NCT00216320 about?
NCT00216320 is a clinical study titled "Efficacy of the WalkAide and AFOs for CVA". To assess the effectiveness of a new stimulator (WalkAide) for the treatment of foot drop. The comparison will involve physical measurements (e.g. walking speed, physiological cost index, Modified Rivermead Mobility Index, etc.) and questionnaires on the quality of life and acceptance of the technol...
What is the current status of trial NCT00216320?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2005-09. Estimated completion is 2008-11.
What conditions does trial NCT00216320 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT00216320?
The interventions under investigation include: WalkAide (DEVICE), AFO (DEVICE).
Who is sponsoring clinical trial NCT00216320?
This trial is sponsored by Innovative Neurotronics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00216320 being conducted?
This trial has 5 study locations across Arizona, California, Missouri, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00216320's enrollment target sits among peer trials
121 116th of 454 higher than 339 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia